Table of Contents 1 Study Coverage 1.1 Hormone Refractory Prostate Cancer (HRPCA) Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size Growth Rate by Product 1.4.2 Chemotherapy 1.4.3 Hormonal Therapy 1.4.4 Immunotherapy 1.4.5 Radiation Therapy 1.4.6 Surgery 1.5 Market by End User 1.5.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size Growth Rate by End User 1.5.2 Hospitals 1.5.3 Ambulatory Surgical Centers 1.5.4 Specialty Clinics 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Market Size 2.1.1 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue 2014-2025 2.1.2 Global Hormone Refractory Prostate Cancer (HRPCA) Sales 2014-2025 2.2 Hormone Refractory Prostate Cancer (HRPCA) Growth Rate by Regions 2.2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Regions 2.2.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Hormone Refractory Prostate Cancer (HRPCA) Sales by Manufacturers 3.1.1 Hormone Refractory Prostate Cancer (HRPCA) Sales by Manufacturers 3.1.2 Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Manufacturers 3.1.3 Global Hormone Refractory Prostate Cancer (HRPCA) Market Concentration Ratio (CR5 and HHI) 3.2 Hormone Refractory Prostate Cancer (HRPCA) Revenue by Manufacturers 3.2.1 Hormone Refractory Prostate Cancer (HRPCA) Revenue by Manufacturers (2014-2019) 3.2.2 Hormone Refractory Prostate Cancer (HRPCA) Revenue Share by Manufacturers (2014-2019) 3.3 Hormone Refractory Prostate Cancer (HRPCA) Price by Manufacturers 3.4 Hormone Refractory Prostate Cancer (HRPCA) Manufacturing Base Distribution, Product Types 3.4.1 Hormone Refractory Prostate Cancer (HRPCA) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Product Type 3.4.3 Date of International Manufacturers Enter into Hormone Refractory Prostate Cancer (HRPCA) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Product 4.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Product 4.3 Hormone Refractory Prostate Cancer (HRPCA) Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Hormone Refractory Prostate Cancer (HRPCA) Breakdown Data by End User 6 North America 6.1 North America Hormone Refractory Prostate Cancer (HRPCA) by Countries 6.1.1 North America Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries 6.1.2 North America Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Hormone Refractory Prostate Cancer (HRPCA) by Product 6.3 North America Hormone Refractory Prostate Cancer (HRPCA) by End User 7 Europe 7.1 Europe Hormone Refractory Prostate Cancer (HRPCA) by Countries 7.1.1 Europe Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries 7.1.2 Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Hormone Refractory Prostate Cancer (HRPCA) by Product 7.3 Europe Hormone Refractory Prostate Cancer (HRPCA) by End User 8 Asia Pacific 8.1 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) by Countries 8.1.1 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries 8.1.2 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) by Product 8.3 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) by End User 9 Central & South America 9.1 Central & South America Hormone Refractory Prostate Cancer (HRPCA) by Countries 9.1.1 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries 9.1.2 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Hormone Refractory Prostate Cancer (HRPCA) by Product 9.3 Central & South America Hormone Refractory Prostate Cancer (HRPCA) by End User 10 Middle East and Africa 10.1 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) by Countries 10.1.1 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries 10.1.2 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) by Product 10.3 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) by End User 11 Company Profiles 11.1 Astellas Inc 11.1.1 Astellas Inc Company Details 11.1.2 Company Business Overview 11.1.3 Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Products Offered 11.1.5 Astellas Inc Recent Development 11.2 Sanofi S.A 11.2.1 Sanofi S.A Company Details 11.2.2 Company Business Overview 11.2.3 Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Products Offered 11.2.5 Sanofi S.A Recent Development 11.3 Dendreon Corporation, Bayer AG 11.3.1 Dendreon Corporation, Bayer AG Company Details 11.3.2 Company Business Overview 11.3.Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Products Offered 11.3.5 Dendreon Corporation, Bayer AG Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Company Business Overview 11.4.3 Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Products Offered 11.4.5 Johnson & Johnson Recent Development 12 Future Forecast 12.1 Hormone Refractory Prostate Cancer (HRPCA) Market Forecast by Regions 12.1.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Regions 2019-2025 12.1.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Regions 2019-2025 12.2 Hormone Refractory Prostate Cancer (HRPCA) Market Forecast by Product 12.2.1 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Product 2019-2025 12.2.2 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Product 2019-2025 12.3 Hormone Refractory Prostate Cancer (HRPCA) Market Forecast by End User 12.4 North America Hormone Refractory Prostate Cancer (HRPCA) Forecast 12.5 Europe Hormone Refractory Prostate Cancer (HRPCA) Forecast 12.6 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Forecast 12.7 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Forecast 12.8 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hormone Refractory Prostate Cancer (HRPCA) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Hormone Refractory Prostate Cancer (HRPCA) Product Picture Table Hormone Refractory Prostate Cancer (HRPCA) Market Segments Table Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Covered Table Global Hormone Refractory Prostate Cancer (HRPCA) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product 2014-2025 Figure Chemotherapy Product Picture Table Major Manufacturers of Chemotherapy Figure Hormonal Therapy Product Picture Table Major Manufacturers of Hormonal Therapy Figure Immunotherapy Product Picture Table Major Manufacturers of Immunotherapy Figure Radiation Therapy Product Picture Table Major Manufacturers of Radiation Therapy Figure Surgery Product Picture Table Major Manufacturers of Surgery Table Global Hormone Refractory Prostate Cancer (HRPCA) Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospitals Figure Ambulatory Surgical Centers Figure Specialty Clinics Figure Hormone Refractory Prostate Cancer (HRPCA) Report Years Considered Figure Global Hormone Refractory Prostate Cancer (HRPCA) Market Size 2014-2025 (Million US$) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales 2014-2025 (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Regions 2014-2019 (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Regions 2014-2019 Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Regions 2014-2019 Figure 2018 Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Regions Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Regions 2014-2019 (Million US$) Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Regions 2014-2019 Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Regions 2014-2019 Figure 2018 Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Regions Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Manufacturers (2014-2019) (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Manufacturers (2014-2019) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Hormone Refractory Prostate Cancer (HRPCA) Revenue by Manufacturers (2014-2019) (Million USD) Table Hormone Refractory Prostate Cancer (HRPCA) Revenue Share by Manufacturers (2014-2019) Figure Hormone Refractory Prostate Cancer (HRPCA) Value Share by Manufacturers in 2018 Table Key Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Price (2014-2019) (USD/Unit) Table Hormone Refractory Prostate Cancer (HRPCA) Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Hormone Refractory Prostate Cancer (HRPCA) Product Type Table Date of International Manufacturers Enter into Hormone Refractory Prostate Cancer (HRPCA) Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by Product (2014-2019) (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by Product (2014-2019) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product (2014-2019) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product in 2018 Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue by Product (2014-2019) (Million US$) Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Share by Product (2014-2019) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Product (2014-2019) Figure Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Product in 2018 Table Hormone Refractory Prostate Cancer (HRPCA) Price by Product 2014-2019 (USD/Unit) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales by End User (2014-2019) (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Share by End User (2014-2019) Figure Global Sales Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User (2014-2019) Figure Global Sales Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User in 2018 Figure North America Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units) Figure North America Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$) Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries (2014-2019) (K Units) Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries (2014-2019) Figure 2018 North America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries Table North America Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries (2014-2019) (Million US$) Table North America Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries (2014-2019) Figure 2018 North America Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries Figure United States Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure United States Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (K Units) Figure Canada Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Canada Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Mexico Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales by Product (2014-2019) (K Units) Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product (2014-2019) Figure 2018 North America Hormone Refractory Prostate Cancer (HRPCA) Market Share by Product Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales by End User (2014-2019) (K Units) Table North America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by End User (2014-2019) Figure 2018 North America Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units) Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$) Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries (2014-2019) (K Units) Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries (2014-2019) Figure 2018 Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries Table Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries (2014-2019) (Million US$) Table Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries Figure Germany Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Germany Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure France Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure France Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure UK Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure UK Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Italy Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Russia Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales by Product (2014-2019) (K Units) Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product (2014-2019) Figure 2018 Europe Hormone Refractory Prostate Cancer (HRPCA) Market Share by Product Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales by End User (2014-2019) (K Units) Table Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by End User (2014-2019) Figure 2018 Europe Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User Figure Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries (2014-2019) (K Units) Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries Figure China Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure China Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Japan Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Korea Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure India Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure India Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Australia Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Philippines Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Thailand Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Singapore Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales by Product (2014-2019) (K Units) Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Market Share by Product Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales by End User (2014-2019) (K Units) Table Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User Figure Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries (2014-2019) (K Units) Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries (2014-2019) (Million US$) Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries Figure Brazil Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Brazil Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Argentina Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales by Product (2014-2019) (K Units) Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Market Share by Product Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales by End User (2014-2019) (K Units) Table Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User Figure Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Countries Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share by Countries Figure GCC Countries Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Turkey Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure Egypt Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate (2014-2019) (K Units) Figure South Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales by Product (2014-2019) (K Units) Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Market Share by Product Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales by End User (2014-2019) (K Units) Table Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Market Share by End User Table Astellas Inc Company Details Table Astellas Inc Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Inc Recent Development Table Sanofi S.A Company Details Table Sanofi S.A Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi S.A Recent Development Table Dendreon Corporation, Bayer AG Company Details Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Dendreon Corporation, Bayer AG Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Hormone Refractory Prostate Cancer (HRPCA) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson Recent Development Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Regions 2019-2025 (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share Forecast by Regions 2019-2025 Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share Forecast by Regions 2019-2025 Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by Product 2019-2025 (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share Forecast by Product 2019-2025 Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Forecast by Product 2019-2025 (Million US$) Table Global Hormone Refractory Prostate Cancer (HRPCA) Revenue Market Share Forecast by Product 2019-2025 Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Forecast by End User 2019-2025 (K Units) Table Global Hormone Refractory Prostate Cancer (HRPCA) Sales Market Share Forecast by End User 2019-2025 Figure North America Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Hormone Refractory Prostate Cancer (HRPCA) Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Hormone Refractory Prostate Cancer (HRPCA) Value Chain Table Hormone Refractory Prostate Cancer (HRPCA) Customers List Table Hormone Refractory Prostate Cancer (HRPCA) Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources